Concanavalin A amplifies both beta-adrenergic and muscarinic cholinergic receptor-adenylate cyclase-linked pathways in cardiac myocytes.
Open Access
- 1 September 1991
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 88 (3) , 760-766
- https://doi.org/10.1172/jci115374
Abstract
Concanavalin A (Con A) is a tetrameric plant lectin that disrupts plasma membrane-cytoskeletal interactions and alters plasma membrane fluidity. We used Con A as a probe to explore beta-adrenergic and muscarinic cholinergic receptor-mediated regulation of cAMP in intact neonatal rat ventricular myocytes. Preincubation with Con A, 0.5 micrograms/ml, attenuated 1 microM (-)-norepinephrine (NE)-induced downregulation of beta-adrenergic receptors and resulted in a 50% augmentation of cAMP accumulation stimulated by 1 microM NE. Con A also augmented forskolin (1-10 microM)-stimulated cAMP accumulation by an average of 37% (P less than 0.05); however, Con A preincubation had no effect on basal or cholera toxin-stimulated cAMP content. The muscarinic cholinergic agonist carbachol (1-100 microM) decreased 1 microM NE-stimulated cAMP generation by an average of 32% (n = 7, P less than 0.05); preincubation with Con A further enhanced the inhibitory effect of carbachol by 18% (n = 7, P less than 0.05). Carbachol (1 microM) for 2 h decreased muscarinic cholinergic receptor density in whole cells by 33%; preincubation with Con A prevented this receptor downregulation. Con A pretreatment did not affect (-)-isoproterenol- or forskolin-stimulated adenylate cyclase activity in cell homogenates, suggesting that an intact cytoarchitecture is necessary for Con A to augment cAMP formation. We conclude that Con A, through its modulation of beta-adrenergic and muscarinic cholinergic receptor signaling, amplifies both stimulatory and inhibitory adenylate cyclase-linked pathways in intact neonatal ventricular myocytes. These data suggest the possibility that plasma membrane-cytoskeletal interaction is an important regulator of transmembrane signaling because interference with this interaction results in alterations in cAMP accumulation mediated by both beta-adrenergic- and muscarinic cholinergic-adenylate cyclase pathways.Keywords
This publication has 35 references indexed in Scilit:
- Effects of acute ischemia in the dog on myocardial blood flow, beta receptors, and adenylate cyclase activity with and without chronic beta blockade.Journal of Clinical Investigation, 1989
- Concanavalin A prevents phorbol-mediated redistribution of protein kinase C and β-adrenergic receptors in rat glioma C6 cellsBiochemical and Biophysical Research Communications, 1987
- Regulation of transmembrane signaling by receptor phosphorylationCell, 1987
- Involvement of microtubules in the isoproterenol-induced ‘down’-regulation of myocardial β-adrenergic receptorsBiochimica et Biophysica Acta (BBA) - Biomembranes, 1983
- Membrane-cytoskeleton interactionBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1983
- Release of Cell-Associated Concanavalin A by Methyl alpha-d-Mannopyranoside Reveals Three Binding States of Conceanavalin-A Receptors on Mouse FibroblastsEuropean Journal of Biochemistry, 1983
- Differentiation of rat myocytes in single cell cultures with and without proliferating nonmyocardial cells. Cross-striations, ultrastructure, and chronotropic response to isoproterenol.Circulation Research, 1982
- Evidence for cytoskeletal associations of the adenylate cyclase system obtained by differential extraction of rat erythrocyte ghostsBiochemical and Biophysical Research Communications, 1981
- Actin-containing matrix associated with the plasma membrane of murine tumour and lymphoid cellsNature, 1981
- RELATIONSHIPS BETWEEN THE STRUCTURE AND ACTIVITIES OF CONCANAVALIN A*Annals of the New York Academy of Sciences, 1974